# Ernexa Therapeutics Inc.: Form 8-K, filed Aug 14, 2020

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2020-08-14
- Accepted by EDGAR: Aug 14, 2020, 17:16 ET
- Period: 2020-08-12
- Accession: 0001493152-20-015948
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315220015948/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315220015948/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315220015948/form8-k.htm

Filed Aug 14, 2020.
Source: SEC EDGAR, the filing index for accession 0001493152-20-015948. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.